S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/Adar1 Capital Management/Q1 2025

Adar1 Capital Management

Periodo: Q1 2025 Β· Depositato: 2025-05-15
Vedi su SEC EDGAR β†—
AUM
$540M
Valore totale del portafoglio
Posizioni
202
Titoli dichiarati
Prima Posizione
PTGX
8.4% $45.4M
Var. Trimestrali
+8 / -8
nuovi Β· usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR β€” non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquiditΓ , obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato Γ¨ il valore nozionale delle azioni sottostanti β€” non il premio pagato. CiΓ² sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo Γ¨ tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con β‰₯$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker Γ¨ a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2025-05-15) si riferisce al titolo sottostante β€” non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
PTGXPROTAGONIST THERAPEUTICS INC$45.4M8.44%$48.36$131.62+172.2%
8.4%
BOXXEA SERIES TRUST$37.6M6.98%$111.49$117.22+5.1%
7.0%
ROIVROIVANT SCIENCES LTD$35.1M6.52%$10.09$35.13+248.2%
6.5%
ZLABZAI LAB LTD$34.0M6.31%$36.14$19.12-47.1%
6.3%
IMVTIMMUNOVANT INC$16.6M3.07%$17.09$38.79+127.0%
3.1%
CYTKCYTOKINETICS INC$15.7M2.92%$40.19$86.49+115.2%
2.9%
KROSKEROS THERAPEUTICS INC$15.2M2.81%$10.19$11.26+10.5%
2.8%
ABVXABIVAX SA$13.8M2.56%$6.25$144.65+2214.4%
2.6%
BILSPDR SER TR$12.4M2.31%$87.35$91.44+4.7%
2.3%
BBIOBRIDGEBIO PHARMA INC$11.7M2.18%$34.57$77.19+123.3%
2.2%
IKTINHIBIKASE THERAPEUTICS INC$11.2M2.08%$2.19$1.99-9.1%
2.1%
SWTXSPRINGWORKS THERAPEUTICS INC$9.2M1.70%β€”β€”
1.7%
SHYISHARES TR$8.6M1.59%$78.99$81.94+3.7%
1.6%
TEVATEVA PHARMACEUTICAL INDS LTD$8.1M1.49%$15.37$34.64+125.4%
1.5%
SRPTSAREPTA THERAPEUTICS INC$7.8M1.46%$63.82$19.28-69.8%
1.5%
PCSCPERCEPTIVE CAP SOLUTIONS COR$7.7M1.43%$10.30$11.00+6.8%
1.4%
CGONCG ONCOLOGY INC$7.4M1.37%$24.49$70.36+187.3%
1.4%
RAPTRAPT THERAPEUTICS INC$7.3M1.35%β€”β€”
1.4%
JANXCALLJANUX THERAPEUTICS INC$7.2M1.33%$27.00$15.54-42.4%
1.3%
ABUSARBUTUS BIOPHARMA CORP$6.6M1.22%$3.49$4.87+39.5%
1.2%
ITCIINTRA-CELLULAR THERAPIES INC$6.3M1.18%β€”β€”
1.2%
RVMDREVOLUTION MEDICINES INC$6.3M1.16%$35.36$189.24+435.2%
1.2%
AVRANTERIS TECHNOLOGIES GLOBAL$6.1M1.13%$3.64$10.24+181.3%
1.1%
AAMAA MISSION ACQUISITION CORP$6.0M1.12%β€”β€”
1.1%
SAGESAGE THERAPEUTICS INC$5.9M1.10%β€”β€”
1.1%
ETNB89BIO INC$5.8M1.09%β€”β€”
1.1%
NVSPUTNOVARTIS AG$5.6M1.03%$108.19$159.90+47.8%
1.0%
COHERUS BIOSCIENCES INC$5.5M1.02%β€”β€”
1.0%
OACCUOAKTREE ACQUISITION CORP III$5.4M1.00%$10.44$11.00+5.4%
1.0%
HLXBHELIX ACQUISITION CORP II$5.3M0.99%β€”β€”
1.0%

AttivitΓ  Trimestre su Trimestre

Q1 2025 vs. Q4 2024

Nuove Posizioni (8)

TickerEmittenteNozionaleDal Deposito
SWTXCALLSPRINGWORKS THERAPEUTICS INC$9.2M
SHYISHARES TR$8.6M+3.7%
ITCIINTRA-CELLULAR THERAPIES INC$6.3M
NVSPUTNOVARTIS AG$5.6M+47.8%
SEPNSEPTERNA INC$4.2M
BRIDGEBIO PHARMA INC$2.7M
ARVNARVINAS INC$2.2M
DVAXDYNAVAX TECHNOLOGIES CORP$2.2M

Posizioni Chiuse (8)

TickerEmittenteNozionale
EDRENDEAVOR GROUP HLDGS INC$6.6M
SNYSANOFI$4.8M
XBISPDR SER TR$4.5M
GOSSAMER BIO INC$4.4M
ASPCUA SPAC III ACQUISITION CORP$2.2M
PLRXPLIANT THERAPEUTICS INC$1.8M
PVLAPALVELLA THERAPEUTICS INC NE$1.7M
AXSMAXSOME THERAPEUTICS INC$1.7M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
AMLXAMYLYX PHARMACEUTICALS INC$5.2M+14615.9%
KROSKEROS THERAPEUTICS INC$14.8M+6294.5%+10.5%
SAGESAGE THERAPEUTICS INC$5.8M+3767.2%
CYTKCYTOKINETICS INC$15.0M+2487.6%+115.2%
RGNXREGENXBIO INC$2.4M+1868.3%
ARDXARDELYX INC$2.3M+1481.3%
GOSSGOSSAMER BIO INC$0.2M+1042.0%
JANXJANUX THERAPEUTICS INC$5.5M+740.7%-42.4%

Ridotte (8)

TickerEmittenteNozionaleVar. Azioni
ASNDASCENDIS PHARMA A/S$-9.6M-98.0%
CLRBXXXXCELLECTAR BIOSCIENCES INC$-0.2M-93.1%
PHATCALLPHATHOM PHARMACEUTICALS INC$-0.4M-81.8%
SLDBSOLID BIOSCIENCES INC$-0.5M-76.8%
OGNORGANON & CO$-0.5M-75.1%
KNSAKINIKSA PHARMACEUTICALS INTL$-2.4M-75.1%
INSMINSMED INC$-1.1M-72.4%
BCRXBIOCRYST PHARMACEUTICALS INC$-0.2M-71.4%
← Torna agli Hedge Fund